Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Elizabeth Pomfret

Concepts (508)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
125
2024
831
17.320
 Why?
Living Donors
74
2023
286
13.050
 Why?
Tissue and Organ Procurement
35
2024
288
6.580
 Why?
Hepatectomy
24
2023
212
3.300
 Why?
Donor Selection
16
2024
75
3.260
 Why?
Tissue Donors
16
2024
391
2.660
 Why?
Kidney Transplantation
15
2024
671
2.530
 Why?
End Stage Liver Disease
12
2023
78
2.460
 Why?
Organ Transplantation
14
2024
228
2.130
 Why?
Carcinoma, Hepatocellular
9
2023
272
2.090
 Why?
Liver
42
2023
1839
2.070
 Why?
Patient Selection
14
2023
662
2.030
 Why?
Perfusion
7
2024
197
1.910
 Why?
Liver Neoplasms
10
2023
640
1.760
 Why?
Postoperative Complications
27
2024
2473
1.610
 Why?
Liver Cirrhosis
9
2020
279
1.390
 Why?
Tissue and Organ Harvesting
10
2024
71
1.350
 Why?
Waiting Lists
15
2023
237
1.230
 Why?
Graft Survival
18
2023
511
1.110
 Why?
Humans
175
2025
129266
1.090
 Why?
Laparoscopy
3
2023
449
1.000
 Why?
Informed Consent
3
2024
167
0.990
 Why?
Fatty Liver
6
2023
230
0.980
 Why?
Hepatitis C, Chronic
5
2022
153
0.960
 Why?
Liver Diseases
5
2023
290
0.880
 Why?
Immunotoxins
4
2025
54
0.810
 Why?
Consensus
9
2024
615
0.800
 Why?
United States
37
2024
13826
0.790
 Why?
Consensus Development Conferences as Topic
2
2020
27
0.790
 Why?
Robotic Surgical Procedures
2
2024
114
0.770
 Why?
Graft Rejection
13
2020
598
0.760
 Why?
Organ Preservation
5
2024
94
0.750
 Why?
Liver Failure
7
2016
91
0.710
 Why?
Surgeons
2
2024
260
0.700
 Why?
Frailty
1
2023
153
0.660
 Why?
Pain, Postoperative
3
2016
233
0.650
 Why?
Adult
71
2024
35495
0.640
 Why?
Portal Vein
4
2017
108
0.630
 Why?
Diphtheria Toxin
4
2025
64
0.620
 Why?
Resource Allocation
4
2013
39
0.610
 Why?
Middle Aged
65
2024
31090
0.590
 Why?
Female
82
2025
68551
0.570
 Why?
Male
83
2024
63512
0.570
 Why?
Treatment Outcome
33
2024
10202
0.560
 Why?
Immunosuppressive Agents
6
2018
854
0.560
 Why?
Hepatic Veins
5
2016
31
0.530
 Why?
Thrombelastography
6
2023
150
0.530
 Why?
Healthcare Disparities
5
2023
575
0.500
 Why?
Antiviral Agents
4
2022
712
0.500
 Why?
Blood Coagulation Disorders
4
2022
167
0.490
 Why?
Venous Thrombosis
1
2017
175
0.490
 Why?
Non-alcoholic Fatty Liver Disease
1
2019
260
0.490
 Why?
Biliary Tract Surgical Procedures
2
2017
25
0.480
 Why?
Transplantation, Homologous
8
2020
400
0.480
 Why?
Biopsy
9
2020
1092
0.470
 Why?
Societies, Medical
4
2024
744
0.470
 Why?
Retrospective Studies
30
2024
14461
0.450
 Why?
Sirolimus
1
2016
266
0.440
 Why?
Kidney
6
2023
1385
0.430
 Why?
Interleukin-2
4
2024
437
0.430
 Why?
Tissue Plasminogen Activator
4
2023
222
0.430
 Why?
Biliary Tract Diseases
2
2010
36
0.420
 Why?
Neoplasm Recurrence, Local
4
2023
958
0.410
 Why?
Hepacivirus
7
2022
235
0.410
 Why?
Tomography, X-Ray Computed
9
2017
2515
0.400
 Why?
Periodicals as Topic
1
2015
204
0.400
 Why?
Kidney Failure, Chronic
3
2023
546
0.380
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2012
99
0.380
 Why?
Hepatitis C
5
2022
238
0.370
 Why?
Lymphoma, T-Cell, Cutaneous
2
2023
43
0.370
 Why?
Survival Rate
13
2023
1869
0.370
 Why?
Transplant Recipients
6
2023
162
0.350
 Why?
Liver Regeneration
4
2003
40
0.350
 Why?
Allografts
3
2023
136
0.340
 Why?
Resuscitation
2
2024
236
0.340
 Why?
Patient Safety
1
2012
285
0.320
 Why?
Blood Coagulation
5
2023
238
0.310
 Why?
Biliary Tract
1
2008
15
0.310
 Why?
Directed Tissue Donation
1
2008
4
0.310
 Why?
Bioethical Issues
1
2008
8
0.310
 Why?
Terminology as Topic
3
2024
203
0.300
 Why?
Vascular Surgical Procedures
1
2011
294
0.300
 Why?
Adolescent
23
2024
20313
0.300
 Why?
Quality of Life
7
2020
2687
0.300
 Why?
Risk Factors
16
2024
9745
0.290
 Why?
Interpersonal Relations
1
2011
391
0.290
 Why?
Software
2
2012
606
0.290
 Why?
Severity of Illness Index
8
2023
2740
0.290
 Why?
Transplants
2
2022
35
0.280
 Why?
Time Factors
15
2024
6543
0.280
 Why?
Tacrolimus
3
2020
193
0.270
 Why?
Registries
5
2024
1895
0.270
 Why?
Fibrinolysis
3
2023
137
0.270
 Why?
Amyloid Neuropathies, Familial
1
2006
14
0.270
 Why?
Young Adult
12
2024
12391
0.270
 Why?
Aged
29
2024
22032
0.260
 Why?
Transplantation Immunology
1
2006
34
0.250
 Why?
Antineoplastic Agents
3
2024
2054
0.250
 Why?
Insurance, Life
1
2005
2
0.250
 Why?
International Cooperation
2
2016
174
0.240
 Why?
Follow-Up Studies
11
2024
4887
0.240
 Why?
CD47 Antigen
1
2025
28
0.230
 Why?
Flank Pain
1
2024
9
0.230
 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2025
26
0.230
 Why?
Renal Nutcracker Syndrome
1
2024
6
0.230
 Why?
Critical Care
4
2024
551
0.230
 Why?
Practice Guidelines as Topic
5
2019
1497
0.230
 Why?
Decision Making
1
2011
849
0.230
 Why?
Health Care Rationing
3
2013
57
0.230
 Why?
Intestines
2
2007
347
0.230
 Why?
Skin Neoplasms
2
2023
824
0.220
 Why?
Solitary Kidney
1
2023
5
0.220
 Why?
Physician-Patient Relations
1
2008
538
0.220
 Why?
Transplantation, Autologous
1
2024
211
0.220
 Why?
Prognosis
9
2024
3773
0.210
 Why?
Risk Assessment
9
2022
3232
0.210
 Why?
Sezary Syndrome
1
2023
44
0.210
 Why?
Body Mass Index
2
2024
2272
0.210
 Why?
Mycosis Fungoides
1
2023
61
0.210
 Why?
Length of Stay
3
2023
1120
0.210
 Why?
Health Knowledge, Attitudes, Practice
1
2011
1276
0.200
 Why?
Body Temperature
1
2023
212
0.200
 Why?
Primary Graft Dysfunction
1
2023
29
0.200
 Why?
Lung Transplantation
2
2024
289
0.200
 Why?
Operative Time
1
2023
124
0.200
 Why?
Thrombosis
3
2022
343
0.190
 Why?
Death
3
2023
117
0.190
 Why?
Adenocarcinoma, Mucinous
1
2023
74
0.190
 Why?
Bile Ducts
2
2022
67
0.190
 Why?
Case-Control Studies
5
2023
3377
0.190
 Why?
Sodium
1
2022
205
0.190
 Why?
Massachusetts
2
2012
159
0.190
 Why?
Antibiotic Prophylaxis
2
2020
101
0.180
 Why?
Evidence-Based Medicine
3
2016
712
0.180
 Why?
Sex Factors
3
2024
1965
0.180
 Why?
Recurrence
10
2011
1005
0.180
 Why?
Prospective Studies
11
2020
7123
0.180
 Why?
Predictive Value of Tests
5
2020
1949
0.180
 Why?
Physicians
2
2010
859
0.180
 Why?
Prothrombin Time
1
2000
33
0.180
 Why?
Cholangitis, Sclerosing
3
2009
71
0.180
 Why?
Bupivacaine
1
2000
30
0.170
 Why?
Analgesia, Epidural
1
2000
23
0.170
 Why?
Reperfusion
1
2020
38
0.170
 Why?
Temperature
1
2023
634
0.170
 Why?
Feasibility Studies
1
2024
867
0.170
 Why?
Epidermal Growth Factor
1
2021
170
0.170
 Why?
Diagnostic Imaging
2
2013
327
0.170
 Why?
Educational Status
3
2022
469
0.170
 Why?
Mitochondrial Encephalomyopathies
1
2020
9
0.170
 Why?
Anesthetics, Local
1
2000
75
0.170
 Why?
Thymidine Phosphorylase
1
2020
14
0.170
 Why?
Costs and Cost Analysis
3
2024
201
0.170
 Why?
Hemostatic Techniques
1
2020
45
0.170
 Why?
Cholestasis
1
2023
232
0.170
 Why?
Blood Component Transfusion
1
2020
82
0.170
 Why?
Carcinoma, Pancreatic Ductal
1
2023
270
0.160
 Why?
Choline
4
1989
124
0.160
 Why?
Policy
1
2021
143
0.160
 Why?
Medicare
1
2024
706
0.160
 Why?
Reproducibility of Results
4
2012
3080
0.160
 Why?
Surgical Wound Infection
1
2022
283
0.160
 Why?
Nephrectomy
1
2020
160
0.160
 Why?
Viremia
1
2020
131
0.160
 Why?
Biliary Atresia
1
2020
161
0.150
 Why?
Risk
3
2016
854
0.150
 Why?
Catheterization
2
2023
174
0.150
 Why?
Gastric Bypass
1
2020
107
0.150
 Why?
Age Distribution
2
2011
372
0.150
 Why?
Amyloid Neuropathies
1
1998
1
0.150
 Why?
Mice, SCID
3
2025
350
0.150
 Why?
Bile Duct Diseases
1
2017
14
0.140
 Why?
Telomerase
1
2020
233
0.140
 Why?
Phlebography
1
2017
37
0.140
 Why?
Prevalence
3
2023
2553
0.140
 Why?
Head and Neck Neoplasms
1
2022
543
0.140
 Why?
Obesity, Morbid
2
2020
240
0.140
 Why?
Premature Birth
1
2021
314
0.140
 Why?
Reoperation
6
2017
541
0.140
 Why?
Drug Overdose
1
2021
322
0.140
 Why?
Incidental Findings
1
2017
79
0.140
 Why?
Asymptomatic Diseases
1
2017
84
0.140
 Why?
Ultrasonography, Doppler
1
2017
118
0.130
 Why?
Bariatric Surgery
1
2020
193
0.130
 Why?
Surveys and Questionnaires
4
2016
5384
0.130
 Why?
Child
8
2022
20785
0.130
 Why?
Incidence
5
2020
2636
0.130
 Why?
Social Determinants of Health
1
2020
220
0.130
 Why?
Cause of Death
2
2021
392
0.130
 Why?
Antibodies, Monoclonal
3
2024
1367
0.130
 Why?
Perioperative Care
1
2017
151
0.130
 Why?
Disease Progression
4
2019
2630
0.130
 Why?
Communicable Diseases
1
2017
147
0.120
 Why?
Iron
1
2017
281
0.120
 Why?
Postoperative Care
1
2017
241
0.120
 Why?
Cohort Studies
8
2021
5409
0.120
 Why?
Postoperative Period
4
2020
329
0.120
 Why?
Morbidity
2
2013
300
0.120
 Why?
Randomized Controlled Trials as Topic
2
2022
1365
0.120
 Why?
Xenograft Model Antitumor Assays
3
2025
812
0.120
 Why?
Pancreatic Neoplasms
1
2023
881
0.120
 Why?
Monitoring, Physiologic
2
1994
265
0.120
 Why?
Chemoembolization, Therapeutic
1
2015
48
0.120
 Why?
Mycophenolic Acid
2
2014
110
0.120
 Why?
Parents
2
2020
1309
0.120
 Why?
Cadaver
3
2015
306
0.110
 Why?
Organ Size
2
2012
446
0.110
 Why?
Antilymphocyte Serum
1
2014
63
0.110
 Why?
Coronary Artery Disease
1
2020
679
0.110
 Why?
Withholding Treatment
1
2014
71
0.110
 Why?
Opioid-Related Disorders
1
2021
483
0.110
 Why?
Comorbidity
1
2019
1544
0.110
 Why?
Mitochondria
1
2020
877
0.110
 Why?
Choline Deficiency
3
1991
11
0.110
 Why?
Steroids
1
2014
158
0.110
 Why?
Splenorenal Shunt, Surgical
2
2006
3
0.100
 Why?
Immunophenotyping
1
2014
310
0.100
 Why?
Thoracic Injuries
1
1993
55
0.100
 Why?
Data Collection
2
2013
647
0.100
 Why?
Physician Executives
1
2013
33
0.100
 Why?
Anticoagulants
1
2017
636
0.100
 Why?
Anesthesiology
1
2013
45
0.100
 Why?
Catheterization, Central Venous
1
1994
103
0.100
 Why?
Receptors, CCR4
2
2024
21
0.100
 Why?
Cooperative Behavior
1
2015
433
0.100
 Why?
Personnel Selection
1
2013
71
0.100
 Why?
Therapeutic Equipoise
1
2011
2
0.100
 Why?
Liver Function Tests
2
2020
112
0.090
 Why?
Mice
6
2025
16915
0.090
 Why?
Mental Health
1
2018
685
0.090
 Why?
Catheter Ablation
1
2015
335
0.090
 Why?
Cell Line, Tumor
3
2025
3202
0.090
 Why?
Mice, Inbred NOD
2
2025
588
0.090
 Why?
Religion
1
2011
67
0.090
 Why?
Anastomosis, Surgical
1
2011
149
0.090
 Why?
Kaplan-Meier Estimate
2
2011
851
0.090
 Why?
Family Relations
1
2011
87
0.090
 Why?
Animals
14
2025
35309
0.090
 Why?
Observer Variation
1
2011
315
0.090
 Why?
Health Status Indicators
1
2011
167
0.090
 Why?
Anastomosis, Roux-en-Y
2
2022
27
0.090
 Why?
Hepatitis, Autoimmune
4
2006
20
0.090
 Why?
Wounds, Nonpenetrating
1
1993
271
0.080
 Why?
Health Planning Guidelines
1
2010
25
0.080
 Why?
Specialties, Surgical
1
2011
73
0.080
 Why?
Hypertension, Portal
1
2010
61
0.080
 Why?
Critical Illness
1
2015
757
0.080
 Why?
Constriction, Pathologic
2
2023
226
0.080
 Why?
Obesity
4
2024
2879
0.080
 Why?
Mutation
1
2020
3710
0.080
 Why?
Models, Biological
2
2006
1722
0.080
 Why?
S-Adenosylmethionine
1
1989
55
0.080
 Why?
North America
2
2023
291
0.080
 Why?
Linear Models
1
2011
819
0.080
 Why?
Proportional Hazards Models
3
2020
1197
0.080
 Why?
Bile Ducts, Intrahepatic
1
2009
65
0.080
 Why?
Life Expectancy
1
2009
60
0.080
 Why?
Rats, Inbred Strains
7
1991
368
0.080
 Why?
Methionine
1
1989
156
0.070
 Why?
Brain Death
2
2024
46
0.070
 Why?
Adrenal Cortex Hormones
1
2011
522
0.070
 Why?
Ventilator Weaning
1
2008
36
0.070
 Why?
General Surgery
1
2010
152
0.070
 Why?
Guidelines as Topic
1
2010
263
0.070
 Why?
Lithium
1
1988
37
0.070
 Why?
Rats
8
2024
5482
0.070
 Why?
Documentation
2
2024
184
0.070
 Why?
Pulmonary Artery
1
1994
1095
0.070
 Why?
Recombinant Fusion Proteins
2
2021
648
0.070
 Why?
Immunoglobulin G
1
2011
848
0.070
 Why?
Hypotension
1
2008
116
0.070
 Why?
Abdomen
2
2024
117
0.070
 Why?
Heart Failure
1
2020
2135
0.070
 Why?
Prealbumin
1
2006
28
0.070
 Why?
Antibodies, Monoclonal, Humanized
1
2011
758
0.070
 Why?
Parenteral Nutrition, Total
2
2003
26
0.060
 Why?
Survival Analysis
4
2015
1269
0.060
 Why?
Demography
1
2007
279
0.060
 Why?
Neoplasm Staging
1
2009
1290
0.060
 Why?
Safety
1
2008
330
0.060
 Why?
Esophageal and Gastric Varices
1
2006
37
0.060
 Why?
Gastrointestinal Hemorrhage
1
2006
121
0.060
 Why?
Transplantation
1
2005
31
0.060
 Why?
Renal Veins
1
2024
16
0.060
 Why?
Algorithms
2
2011
1613
0.060
 Why?
Practice Patterns, Physicians'
1
2013
1267
0.060
 Why?
Pain
2
2022
786
0.060
 Why?
Xanthomatosis
1
2004
11
0.050
 Why?
Employment
1
2005
167
0.050
 Why?
Swine, Miniature
1
2024
81
0.050
 Why?
Salvage Therapy
1
2024
133
0.050
 Why?
Granuloma
1
2004
89
0.050
 Why?
Bilirubin
1
2023
96
0.050
 Why?
Depression
2
2018
1306
0.050
 Why?
Patient Care
1
2004
108
0.050
 Why?
Liver Cirrhosis, Biliary
1
2003
18
0.050
 Why?
Shock
1
2024
92
0.050
 Why?
Choledochostomy
1
2022
11
0.050
 Why?
T-Lymphocytes
2
2014
1933
0.050
 Why?
Perioperative Period
1
2022
49
0.050
 Why?
Infant
3
2021
8975
0.050
 Why?
Syndrome
1
2023
339
0.050
 Why?
Research
1
2006
416
0.050
 Why?
Laboratories
1
2023
108
0.050
 Why?
Platelet Count
1
2022
82
0.050
 Why?
Mentors
1
2024
178
0.050
 Why?
Liver Cirrhosis, Alcoholic
1
2002
17
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2022
84
0.050
 Why?
Propensity Score
1
2023
263
0.050
 Why?
Cell Differentiation
1
2009
1887
0.050
 Why?
Platelet Transfusion
1
2022
59
0.050
 Why?
Pain Measurement
1
2024
506
0.050
 Why?
RNA, Viral
3
2013
619
0.050
 Why?
Patients
1
2023
167
0.050
 Why?
Hypophosphatemia
1
2001
17
0.050
 Why?
Swine
1
2024
760
0.050
 Why?
Creatinine
1
2023
491
0.050
 Why?
Family
1
2005
644
0.050
 Why?
Leukocytes, Mononuclear
1
2024
545
0.040
 Why?
Erlotinib Hydrochloride
1
2021
70
0.040
 Why?
Intraoperative Period
1
2020
53
0.040
 Why?
Histocompatibility Testing
1
2020
120
0.040
 Why?
Computer Systems
1
2020
44
0.040
 Why?
Pancreas
1
2023
304
0.040
 Why?
Viscosity
1
2020
90
0.040
 Why?
Preoperative Care
1
2022
339
0.040
 Why?
Thymidine
1
2020
59
0.040
 Why?
Inhibitory Concentration 50
1
2020
86
0.040
 Why?
Infant, Newborn
2
2021
5736
0.040
 Why?
Kidney Function Tests
1
2020
152
0.040
 Why?
Esophageal Motility Disorders
1
2020
26
0.040
 Why?
Interleukin-2 Receptor alpha Subunit
1
2020
82
0.040
 Why?
Remission Induction
1
2020
271
0.040
 Why?
HLA-DR Antigens
1
2020
223
0.040
 Why?
Sex Distribution
1
2020
359
0.040
 Why?
ErbB Receptors
1
2022
605
0.040
 Why?
Image Processing, Computer-Assisted
2
2001
742
0.040
 Why?
Hemangioma, Cavernous
1
1999
14
0.040
 Why?
Gastrectomy
1
2020
100
0.040
 Why?
Renal Dialysis
1
2023
423
0.040
 Why?
Blood Platelets
1
2022
380
0.040
 Why?
HLA Antigens
1
2020
234
0.040
 Why?
Age Factors
2
2021
3140
0.040
 Why?
Peripheral Nervous System Diseases
1
2020
125
0.040
 Why?
Pregnancy Outcome
1
2021
389
0.040
 Why?
Hypertension, Pulmonary
1
2010
1894
0.040
 Why?
Tumor Microenvironment
1
2022
631
0.040
 Why?
Pilot Projects
2
2014
1584
0.040
 Why?
Coronary Angiography
1
2020
305
0.040
 Why?
Longitudinal Studies
1
2005
2715
0.040
 Why?
Anatomic Variation
1
2017
3
0.040
 Why?
Hepcidins
1
2017
22
0.040
 Why?
Mammary Glands, Animal
2
1988
120
0.040
 Why?
Nervous System
1
1998
67
0.040
 Why?
Pancreas Transplantation
2
2009
75
0.040
 Why?
Ferritins
1
2017
58
0.040
 Why?
Boston
1
2017
87
0.040
 Why?
Chi-Square Distribution
2
2011
514
0.040
 Why?
Hepatic Artery
3
2003
59
0.030
 Why?
Phosphatidylcholines
2
1988
145
0.030
 Why?
Recombinant Proteins
1
2020
1304
0.030
 Why?
Analgesics, Opioid
1
2024
909
0.030
 Why?
Cardiovascular System
1
1998
136
0.030
 Why?
Communication
1
2022
836
0.030
 Why?
Sepsis
1
2022
572
0.030
 Why?
Flow Cytometry
1
2020
1155
0.030
 Why?
Databases, Factual
1
2021
1266
0.030
 Why?
Immunocompromised Host
1
2017
198
0.030
 Why?
Hepatic Encephalopathy
1
2015
19
0.030
 Why?
Hepatorenal Syndrome
1
2015
14
0.030
 Why?
Acute-On-Chronic Liver Failure
1
2015
7
0.030
 Why?
Cross Infection
1
1998
217
0.030
 Why?
Fatigue
1
2018
316
0.030
 Why?
Contrast Media
2
2013
393
0.030
 Why?
Contraindications
2
2006
90
0.030
 Why?
Peritonitis
1
2015
81
0.030
 Why?
Benchmarking
1
2016
176
0.030
 Why?
Protein Kinase Inhibitors
1
2021
890
0.030
 Why?
Aged, 80 and over
4
2011
7055
0.030
 Why?
Cluster Analysis
1
2016
479
0.030
 Why?
Delivery of Health Care
1
2022
892
0.030
 Why?
Fluid Therapy
1
2015
133
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2020
572
0.030
 Why?
Host-Pathogen Interactions
1
2017
351
0.030
 Why?
Mesothelioma
2
1985
38
0.030
 Why?
Social Class
1
2016
258
0.030
 Why?
Blood Transfusion
1
2016
295
0.030
 Why?
Genotype
2
2013
1835
0.030
 Why?
Peritoneal Neoplasms
2
1985
87
0.030
 Why?
Equipment Failure
1
1994
105
0.030
 Why?
Constitution and Bylaws
1
2013
1
0.030
 Why?
Pandemics
1
2021
1481
0.030
 Why?
Decision Trees
1
1993
90
0.030
 Why?
Hospitals, Low-Volume
1
2013
22
0.030
 Why?
Respiratory Mechanics
1
1993
64
0.030
 Why?
Pediatrics
1
2001
1049
0.030
 Why?
Hospitals, High-Volume
1
2013
39
0.030
 Why?
Rabbits
1
2014
777
0.030
 Why?
Chromatography, High Pressure Liquid
3
1991
580
0.030
 Why?
Certification
1
2013
94
0.020
 Why?
Viral Envelope Proteins
1
2013
81
0.020
 Why?
Clinical Protocols
1
1993
254
0.020
 Why?
Multivariate Analysis
1
2015
1497
0.020
 Why?
Cost-Benefit Analysis
1
2014
569
0.020
 Why?
Alcoholism
1
2018
765
0.020
 Why?
Health Care Surveys
1
2013
557
0.020
 Why?
Patient Readmission
1
2016
652
0.020
 Why?
Emotions
1
2016
538
0.020
 Why?
Anxiety
1
2018
962
0.020
 Why?
Cardiopulmonary Resuscitation
1
1993
232
0.020
 Why?
Education
1
2011
100
0.020
 Why?
Biomechanical Phenomena
1
1993
757
0.020
 Why?
Pregnancy
2
2021
6390
0.020
 Why?
Polymerase Chain Reaction
2
2004
1036
0.020
 Why?
Research Design
1
2016
1043
0.020
 Why?
Biological Transport
2
1988
404
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2011
0.020
 Why?
Respiratory Insufficiency
1
1993
313
0.020
 Why?
Diagnosis, Differential
2
2004
1432
0.020
 Why?
Methotrexate
1
1991
248
0.020
 Why?
Diabetes Mellitus
1
1998
1000
0.020
 Why?
Folic Acid
1
1991
184
0.020
 Why?
Ursodeoxycholic Acid
1
2009
19
0.020
 Why?
Cholagogues and Choleretics
1
2009
8
0.020
 Why?
Ethics, Medical
1
2010
78
0.020
 Why?
Workload
1
2011
153
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
1989
131
0.020
 Why?
Leadership
1
2013
353
0.020
 Why?
Education, Medical, Graduate
1
2013
438
0.020
 Why?
Guideline Adherence
1
2013
526
0.020
 Why?
Drug Therapy, Combination
1
2011
1040
0.020
 Why?
Phosphatidylethanolamines
1
1988
74
0.020
 Why?
Life Style
1
2011
459
0.020
 Why?
Health Policy
1
2011
351
0.020
 Why?
Prednisone
1
2009
233
0.020
 Why?
Double-Blind Method
1
2013
1875
0.020
 Why?
Methyltransferases
1
1988
70
0.020
 Why?
Magnetic Resonance Imaging
1
2020
3386
0.020
 Why?
Blood Glucose
1
1998
2097
0.020
 Why?
Gastroenterology
1
2010
174
0.020
 Why?
Academic Medical Centers
1
2011
474
0.020
 Why?
Breast
1
1988
153
0.020
 Why?
Acute Kidney Injury
1
2015
790
0.020
 Why?
Models, Theoretical
1
2011
546
0.020
 Why?
Betaine
1
1988
75
0.020
 Why?
Selenium Compounds
1
1987
21
0.020
 Why?
Selenium
1
1987
36
0.020
 Why?
Needs Assessment
1
2010
359
0.020
 Why?
Child, Preschool
1
2021
10459
0.020
 Why?
Organometallic Compounds
1
1987
106
0.020
 Why?
Fellowships and Scholarships
1
2010
273
0.020
 Why?
Biomarkers
1
2017
3968
0.020
 Why?
Intubation, Intratracheal
1
2008
239
0.020
 Why?
Clinical Competence
1
2013
1016
0.020
 Why?
Survivors
1
2009
457
0.020
 Why?
Anti-Inflammatory Agents
1
2009
480
0.020
 Why?
Cross-Sectional Studies
1
2016
5050
0.010
 Why?
Podophyllotoxin
1
1984
7
0.010
 Why?
Etoposide
1
1984
148
0.010
 Why?
Carcinoma, Small Cell
1
1984
169
0.010
 Why?
Tissue Adhesions
1
2004
30
0.010
 Why?
Lacerations
1
2004
29
0.010
 Why?
Liver Diseases, Alcoholic
1
2004
89
0.010
 Why?
Curriculum
1
2010
910
0.010
 Why?
Internship and Residency
1
2013
1047
0.010
 Why?
Intraoperative Complications
1
2004
129
0.010
 Why?
Intestinal Mucosa
1
1988
589
0.010
 Why?
Angiography
1
2003
196
0.010
 Why?
Hepatitis C Antibodies
1
2002
9
0.010
 Why?
Inflammation
1
1993
2737
0.010
 Why?
Erythrocytes
1
1988
673
0.010
 Why?
Azathioprine
1
2001
50
0.010
 Why?
Blood Pressure
1
2008
1736
0.010
 Why?
Spleen
1
2003
506
0.010
 Why?
Secondary Prevention
1
2001
218
0.010
 Why?
Ischemia
1
2003
406
0.010
 Why?
Inflammatory Bowel Diseases
1
2003
320
0.010
 Why?
Autoimmune Diseases
1
2003
426
0.010
 Why?
APACHE
1
1998
65
0.010
 Why?
Imaging, Three-Dimensional
1
2001
529
0.010
 Why?
Surgical Procedures, Operative
1
1999
244
0.010
 Why?
Diabetes Complications
1
1998
224
0.010
 Why?
Sensitivity and Specificity
1
2000
1839
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1983
1556
0.010
 Why?
Lung Neoplasms
1
1984
2342
0.010
 Why?
Combined Modality Therapy
2
1985
1199
0.010
 Why?
Pteroylpolyglutamic Acids
1
1991
1
0.010
 Why?
Tetrahydrofolates
1
1991
18
0.010
 Why?
Phosphatidylethanolamine N-Methyltransferase
1
1988
8
0.000
 Why?
Hemicholinium 3
1
1988
1
0.000
 Why?
Dinitrophenols
1
1988
8
0.000
 Why?
2,4-Dinitrophenol
1
1988
9
0.000
 Why?
Ouabain
1
1988
18
0.000
 Why?
Osmolar Concentration
1
1988
166
0.000
 Why?
Methylation
1
1988
230
0.000
 Why?
Selenium Radioisotopes
1
1987
2
0.000
 Why?
Selenious Acid
1
1987
3
0.000
 Why?
Selenomethionine
1
1987
3
0.000
 Why?
Milk
1
1988
119
0.000
 Why?
Lactation
1
1988
169
0.000
 Why?
Epithelium
1
1988
311
0.000
 Why?
In Vitro Techniques
1
1988
1085
0.000
 Why?
Drug Evaluation
1
1984
82
0.000
 Why?
Kinetics
1
1988
1644
0.000
 Why?
Asbestos
1
1983
28
0.000
 Why?
Laparotomy
1
1983
106
0.000
 Why?
Epithelial Cells
1
1988
1063
0.000
 Why?
Palliative Care
1
1985
706
0.000
 Why?
Pomfret's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (508) concept(s)
_
Co-Authors Expand Description
See all (61) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)